TitleA Propositional Approach for Genome-Guided Supplementation of Environmental Substrates to Induce Silent Biosynthetic Gene Clusters in ActinomycetesRunning TitlePropositional Activation of Silent BGCs via Genome-Guided ElicitorsAuthorMaxwel A. Abegg Institute of Exact Sciences and Technology (ICET), Graduate Program in Sciences, Technology and Health (PPGCTS), Federal University of Amazonas (UFAM), Itacoatiara, Brazil ORCID: 0000-0002-0328-1122 | maxabegg@gmail.comAbstractThe pervasive transcriptional silence of biosynthetic gene clusters (BGCs) in actinomycetes under standard laboratory conditions limits access to their full metabolic potential. We propose a conceptual, genome-guided protocol that uses comparative mining of both actinomycete genomes and genomes of co-occurring Gram-negative bacteria to identify with higher confidence which small molecules may activate silent BGCs. Mining the producer’s genome locates cluster-situated regulators (e.g., LuxR-like proteins) and identifies key enzymatic domains—such as NRPS adenylation domains—whose sequence features can be analyzed by specialized tools (e.g., NRPSpredictor2, SANDPUMA) to predict which amino acid substrates the cluster may incorporate. Simultaneously, mining competitor genomes uncovers their quorum-sensing and siderophore pathways (e.g., AHL synthases, enterobactin operons), indicating which interspecies signals are likely present in that habitat. By selecting elicitors—such as long-chain N-acyl homoserine lactones (AHLs), enterobactin, sodium bromide, and L-tryptophan—that align with both the producer’s regulatory elements and competitors’ signals, we aim to target silent BGCs more effectively. Deployment of devices in supplemented, sterile substrates for 2–4 weeks is intended to recreate these ecological cues under controlled conditions, potentially facilitating discovery of novel secondary metabolites. This protocol remains untested in the field due to technical and financial constraints, but we present it conservatively to encourage exploration of new approaches for activating silent BGCs.Keywords: Actinomycetes; Biosynthetic Gene Clusters; Genome Mining; Chemical Elicitors; iChip; In Situ CultivationIntroductionActinomycetes harbor dozens of biosynthetic gene clusters (BGCs) in their genomes, yet the majority of these clusters remain transcriptionally silent under conventional laboratory cultivation, leaving a vast reservoir of potentially novel natural products unexplored [1,2]. Genomic surveys indicate that a singleStreptomyces genome may encode 30–50 BGCs, but less than 10% of these are expressed when grown on standard agar or broth media [1,3]. This disconnect arises because laboratory media often lack key environmental signals—nutrient limitations, interspecies cues, or abiotic stresses—necessary to trigger cluster activation. Consequently, many actinomycete-derived metabolites remain undetected, hindering drug discovery efforts.Several approaches have been developed to awaken cryptic BGCs. Manipulating culture conditions via OSMAC (One Strain–Many Compounds) can reveal new metabolites by varying carbon, nitrogen, or trace element sources [3]. Co-cultivation with other microorganisms has been shown to stimulate interspecies signaling that derepresses silent clusters [4]. Genetic methods, including heterologous expression of regulatory genes or deletion of pathway repressors, have successfully refactored silent clusters [5]. Chemical elicitation, using small-molecule inducers such as subinhibitory antibiotics or epigenetic modifiers, has also unlocked cryptic pathways [6]. Despite these advances, identifying which environmental signals specifically activate a given BGC remains challenging, because most methods rely on trial-and-error screening of large elicitor libraries or extensive genetic manipulation. This gap motivates a more targeted, genome-guided strategy.Here, we propose a protocol to activate silent BGCs in actinomycetes by integrating comparative genome mining with rational selection of chemically stable, ecologically relevant elicitors and in situ cultivation. Specifically, we hypothesize that (1) genomic analysis of the producer strain can reveal cluster-situated regulators (e.g., LuxR-like proteins, two-component system sensors) and core enzymatic domains whose predicted substrate specificities guide precursor supplementation; (2) mining genomes of co-occurring Gram-negative bacteria identifies quorum-sensing and siderophore pathways that suggest interspecies signals present in the native habitat; and (3) by supplementing environmental matrices with elicitors aligned to both producer regulators and competitor signals—and incubating in diffusion chambers or iChips within sterile substrates—silent BGCs can be derepressed without extensive genetic manipulation. This targeted approach aims to reduce randomness in BGC activation, leveraging ecological context and bioinformatic predictions to focus on a smaller set of candidate elicitors.To perform the in silico analyses and manage data efficiently, we recommend the following software tools:antiSMASH : Annotates and predicts BGC regions within microbial genomes.DeepBGC : Uses machine-learning classifiers to detect BGCs not captured by traditional homology searches.CoreFinder : Refines functional annotations within BGCs by applying a context-aware protein-language model to recognize enzymatic domains (e.g., halogenases, methyltransferases).CHAMOIS : Translates Pfam domain annotations into predicted chemical scaffolds and precursor dependencies, thereby guiding elicitor selection.NRPSpredictor2 & SANDPUMA : Predict amino acid substrate specificity of NRPS adenylation domains by comparing signature residues against database profiles.BLAST : Identifies homologous genes in competitor genomes, such as quorum-sensing synthases (LuxI homologs) and outer membrane porins (OmpF/OprF).GNPS (Global Natural Products Social Molecular Networking) : Facilitates molecular networking of LC-MS/MS data to group related metabolites and highlight novel compounds.SIRIUS : Performs in silico fragmentation analysis for structural elucidation of unknown metabolites.These tools collectively enable genome mining, substrate-preference prediction, homolog identification, and metabolomic data interpretation, forming the computational backbone of our proposed protocol.Methodology1. Comparative Genome Mining and Elicitor Selection1.1 Producer Genome Analysis antiSMASH & DeepBGCAnnotate all BGC regions in the actinomycete genome, highlighting core enzymatic domains (e.g., ketosynthase, adenylation, precursor peptides) and cluster-situated regulators (e.g., LuxR-like transcription factors).CoreFinder & CHAMOISApply CoreFinder to refine functional annotation within each predicted BGC, confirming domains such as halogenases or methyltransferases.Use CHAMOIS to translate Pfam domain annotations into predicted chemical features (e.g., likely phenazine or siderophore scaffolds), thereby guiding which elicitors or precursors may be most relevant.NRPSpredictor2 / SANDPUMAFor each NRPS adenylation domain detected by antiSMASH/DeepBGC, analyze signature residues to infer the preferred amino acid substrate (e.g., L-tryptophan or L-phenylalanine).Record high-confidence predictions (probability ≥ 0.90) to inform precursor supplementation.1.2 Competitor Genome Analysis antiSMASH & DeepBGCScreen co-occurring Gram-negative genomes for quorum-sensing clusters (LuxI/LuxR homologs) and siderophore biosynthesis clusters (e.g., enterobactin operons).BLAST SearchesIdentify genes encoding outer membrane porins (e.g., OmpF, OprF) whose peptide fragments may mimic cell-envelope stress signals.Inference of Ecological SignalsPresence of a long-chain AHL synthase (e.g., 3-oxo-C12-HSL) indicates that corresponding AHLs are authentic interspecies signals in the producer’s habitat.Detection of an enterobactin operon suggests iron limitation is signaled by enterobactin, potentially activating siderophore BGCs in actinomycetes.Identification of porin genes implies that porin-derived peptides may trigger membrane-stress responsive clusters.Overlay of Producer and Competitor InsightsCross-reference cluster-situated regulators with competitor-derived signals to shortlist candidate elicitors that (a) have affinity for the actinomycete’s regulatory network and (b) emulate genuine environmental cues.2. Selection of Environmentally Relevant ElicitorsExamples of potential elicitors revealed by comparative genome analyses include:Long-Chain AHLs (e.g., 3-oxo-C12-HSL): Selected when competitor genomes encode corresponding AHL synthases; these molecules may cross-activate LuxR-like regulators in actinomycetes.Enterobactin : Emulates iron limitation; chosen if competitor genomes harbor enterobactin operons, potentially inducing siderophore BGCs in actinomycetes.Porin-Derived Peptides (10–15 amino acids from OmpF/OprF): Mimic outer membrane stress, potentially triggering stress-responsive BGCs.Sodium Bromide (NaBr) : Provides halide ions to support halogenase-containing BGCs predicted by CHAMOIS.Amino Acids (e.g., L-tryptophan, L-phenylalanine): Serve as precursors when NRPSpredictor2/SANDPUMA predict these as NRPS substrates.Alternative Carbon Sources (e.g., mannitol, trehalose): Maintain basal microbial growth without repressing secondary metabolism.Stock PreparationDissolve each elicitor in sterile water or buffer to prepare concentrated stocks (e.g., 10 mM AHL, 10 mM enterobactin, 100 mM NaBr, 100 mM amino acids).Matrix Sterilization and EnrichmentObtain an environmental matrix (e.g., leaf litter, humic soil, decomposed wood) and sterilize by autoclaving (121 °C, 20 min) to eliminate native microbial communities.Incorporate elicitor stocks into the sterile matrix at empirically determined final concentrations—e.g.:• 50 µM long-chain AHL • 1 mM enterobactin • 5 mM NaBr • 5 mM L-tryptophan • 1–2% (w/v) mannitol or trehaloseEquilibrate the supplemented matrix at ambient temperature for 12–24 h to ensure uniform distribution of elicitors.3. In Situ Cultivation Using Diffusion Chambers or iChipsDevice DescriptionDiffusion Chambers [14]: Two-part devices sealed with 0.03 µm semipermeable membranes that allow passive diffusion of small molecules from the environment into an agar-based inoculum.iChips [15]: High-throughput, multiwell devices, each well containing an individual cell or colony separated by semipermeable membranes; designed to replicate in situ conditions with minimal disturbance to native cues.Inoculum PreparationHarvest actinomycete spores or cells (10^4–10^6 CFU/mL) and suspend in 0.5–1% (w/v) agar or gellan-gum solution.Pipette ~5 µL of the inoculum into each diffusion chamber or iChip well.Seal wells with semipermeable membranes, ensuring airtight contact.DeploymentEmbed diffusion chambers or iChips within the elicitor-supplemented, sterile matrix, ensuring intimate contact between membrane and substrate.Maintain substrate moisture at ~40–60% water-holding capacity by periodic addition of sterile water; avoid waterlogging.Incubate devices in situ for 2–4 weeks (up to 30 days if needed). Position them in shaded or semi-shaded locations to prevent rapid desiccation and extreme temperatures. Since the substrate is sterile and enriched only with selected elicitors, any detected metabolites can be attributed to the inoculated producer.Downstream Applications4. Gene Expression MonitoringRNA Extraction & RT-qPCRRetrieve devices; aseptically recover agar/gellan-gum carriers containing cells.Disrupt carriers mechanically (e.g., bead beating) and extract total RNA using an RNA purification kit compatible with environmental samples.Treat RNA with DNase I to remove genomic DNA.Synthesize cDNA using random hexamer primers.Design primers targeting:• Core biosynthetic genes (e.g., ketosynthase domains in PKS, adenylation domains in NRPS). • Cluster-situated regulators (e.g., LuxR-like transcription factors).Place primers within –192 to –66 bp upstream of start codons, where transcription-factor binding is often concentrated.Normalize expression against housekeeping genes (e.g., rpoB, gyrA).Use the ΔΔCₜ method to compare expression levels in elicited versus control samples, thereby assessing whether silent BGCs exhibit upregulated transcription. Because the substrate is sterile, background expression from contaminating microbes is minimized, yielding more accurate relative quantification of the producer’s transcripts.5. Metabolite Detection and ProfilingLC-HRMSExtract metabolites from carriers and surrounding matrix using organic solvents (e.g., methanol, ethyl acetate).Concentrate extracts under reduced pressure and reconstitute in an LC-MS–compatible solvent (e.g., 50% acetonitrile with 0.1% formic acid).Analyze extracts on a high-resolution LC-MS system, employing gradients optimized for separation of polyketides, nonribosomal peptides, and small polar compounds.Compare induced versus uninduced chromatograms to identify novel peaks corresponding to elicited metabolites.Utilize GNPS for molecular networking and SIRIUS (or similar tools) for in silico fragmentation, proposing structures guided by CHAMOIS-predicted formulas. Because the substrate began as sterile and only the inoculated actinomycete contributes metabolites, any new mass features likely represent elicitor-driven products.MALDI-TOF MSSpot crude extracts onto a MALDI plate with an appropriate matrix (e.g., α-cyano-4-hydroxycinnamic acid).Acquire mass spectra to rapidly screen for new mass features indicative of elicited compounds. Minimal substrate background facilitates detection of low-abundance producer-derived ions.ConclusionThis technical framework outlines a conceptually grounded approach—based on comparative genome mining—to select ecologically relevant elicitors and deploy diffusion chambers or iChips in sterile, supplemented substrates, thereby recreating native environmental cues under controlled conditions that favor direct comparison of metabolite expression. By identifying cluster-situated regulators and predicted substrate specificities in actinomycete genomes, alongside quorum-sensing and siderophore pathways in competitor bacteria, one can assemble a targeted elicitor suite. Devices such as diffusion chambers and iChips offer minimally invasive, in situ cultivation platforms to test these elicitor combinations. Sterilizing the environmental matrix ensures that observed metabolites arise from the inoculated producer, simplifying downstream analyses. Ultimately, careful validation of this framework could broaden access to cryptic secondary metabolites and inspire new avenues for natural product discovery.ReferencesRui S, Fengrui G, Zhang Y, et al. Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review. Front Microbiol. 2025 May;16:1550516. doi:10.3389/fmicb.2025.1550516.Coelho LP, Alves R, Rodríguez del Río Á, et al. Towards the biogeography of prokaryotic genes. Nature. 2022;601(7892):252–256. doi:10.1038/s41586-022-04271-8.Ribeiro Monteiro S, Kerdel Y, Gathot J, Rigali S. The Transcriptional Architecture of Bacterial Biosynthetic Gene Clusters. bioRxiv. 2025 Mar 19; doi:10.1101/2025.03.18.644061.Covington BC, Xu F, Seyedsayamdost MR. A Natural Product Chemist’s Guide to Unlocking Silent Biosynthetic Gene Clusters. Annu Rev Biochem. 2021;90:763–788.Kang Z, Zhang H, Liang C, Yang R, Ye Y, Bai H, et al. Deciphering Biosynthetic Gene Clusters with a Context-aware Protein Language Model. bioRxiv. 2025 May 03; doi:10.1101/2025.04.29.651206.Kurtböke İ. Actinomycetes: what more can they offer in an era of metabolic engineering and artificial intelligence? Microbiology Australia. 2025;46(2):72–76. doi:10.1071/MA25022.Schniete JK, Fernández-Martínez LT. Natural product discovery in soil actinomycetes: unlocking their potential within an ecological context. Curr Opin Microbiol. 2024;79:102487. doi:10.1016/j.mib.2024.102487.Pinedo-Rivilla C, Aleu J, Durán-Patrón R. Cryptic Metabolites from Marine-Derived Microorganisms Using OSMAC and Epigenetic Approaches. Mar Drugs. 2022;20(2):84. doi:10.3390/md20020084.Yook G, Nam J, Jo Y, Yoon H, Yang D. Metabolic engineering approaches for the biosynthesis of antibiotics. Microbial Cell Factories. 2025;24:35.Libis V, MacIntyre LW, Mehmood R, et al. Multiplexed mobilization and expression of biosynthetic gene clusters. Nat Commun. 2022;13:5256. doi:10.1038/s41467-022-32858-0.Tay DWP, Tan LL, Heng E, et al. Exploring a general multi-pronged activation strategy for natural product discovery in Actinomycetes. Commun Biol. 2024;7:50. doi:10.1038/s42003-023-05648-7.Salamzade R, Kalan LR. Context matters: assessing the impacts of genomic background and ecology on microbial biosynthetic gene cluster evolution. mSystems. 2025;10(3):e01538-24. doi:10.1128/msystems.01538-24.Arivuselvam R, Nagappan K, Raj PV, Rajeshkumar R. Unveiling Nature’s Secrets: Activating Silent Biosynthetic Gene Clusters in Fungi and Bacteria. Int J Nutr Pharmacol Neurol Dis. 2024;14:292–299.Kaeberlein T, Lewis K, Epstein SS. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science. 2002;296(5570):1127–1129.Nichols D, Cahoon N, Trakhtenberg EM, Pham L, Mehta A, Belanger A, Kanigan T, Lewis K, Epstein SS. Use of iChip for high-throughputin situ cultivation of “uncultivable” microbial species. Environ Microbiol. 2010;12(12):348–355.